BioTrinity

BioTrillion is a health technology company developing a digital biomarker platform called BioEngine4D. The platform leverages smartphone sensors, such as cameras, to capture physiological data from the face and eyes and uses AI and computer vision to detect early signs of disease. Its mission is to democratize healthcare by enabling large-scale, non-invasive health monitoring and accelerating drug development through decentralized clinical trials. The company's technology has been independently evaluated to measure 10 medically established vital signs and digital biomarkers with high accuracy, providing orthogonal windows into autonomic, neurologic, and cardiovascular health.